research use only

Relebactam β-lactamase inhibitor

Cat.No.S0074

Relebactam (MK-7655) is a potent inhibitor against KPC-2, class A and class C (AmpC) β-lactamases.
Jump to

Quality Control

Batch: Purity: 99.75%
99.75

Solubility

In vitro
Batch:

DMSO : 70 mg/mL (200.93 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 70 mg/mL

Ethanol : Insoluble

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 348.38 Formula

C12H20N4O6S

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 1174018-99-5 -- Storage of Stock Solutions

Synonyms MK-7655 SMILES C1CC(N2CC1N(C2=O)OS(=O)(=O)O)C(=O)NC3CCNCC3

Read more about storage stability stock solution CAS number SMILES

Mechanism of Action

Targets/IC50/Ki
β-lactamase
References

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2026-08-12)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT07759453 NOT_YET_RECRUITING
Liver Transplant; Carbapenem-resistant Enterobacterales; CRE Colonization
IRCCS Azienda Ospedaliero-Universitaria di Bologna
2026-10-01 PHASE3
NCT05561764 TERMINATED
Cystic Fibrosis; Pneumonia, Bacterial
Hartford Hospital
2023-01-03 PHASE4
NCT05204563 COMPLETED
Hospital Acquired Bacterial Pneumonia or Ventilator-Associated Bacterial Pneumonia
Evopoint Biosciences Inc.
2022-07-31 PHASE3
NCT04983901 COMPLETED
Hematopoietic and Lymphoid Cell Neoplasm; Malignant Solid Neoplasm
M.D. Anderson Cancer Center
2021-09-14 PHASE2
NCT05146154 WITHDRAWN
Obesity; Critical Illness
University of Illinois at Chicago
2023-01-01 PHASE4
NCT04493151 COMPLETED
Sepsis
Joseph L. Kuti, PharmD
2021-01-01 PHASE1

Read more about Clinical Trials

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.